GC16 GC16 Biología celular en hematología. Hipercoagulabilidad

Sargas C, Ayala R, Larrayoz MJ, Chillon MC, Rodriguez-Arboli E, Bilbao C, de la Torre EP, Martinez-Cuadron D, Rodriguez-Veiga R, Boluda B, Gil C, Bernal T, Bergua J, Algarra L, Tormo M, Martinez-Sanchez P, Soria E, Serrano J, Alonso-Dominguez JM, Garcia R, Amigo ML, Herrera-Puente P, Sayas MJ, Lavilla-Rubira E, Martinez-Lopez J, Calasanz MJ, Garcia-Sanz R, Perez-Simon JA, Casares MTG, Sanchez-Garcia J, Barragan E, Montesinos P

Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group

BLOOD CANCER JOURNAL

DOI: 10.1038/s41408-023-00835-5

Aparicio-Perez C, de la Torre EP, Sanchez-Garcia J, Martin-Calvo C, Martinez-Losada C, Casano-Sanchez J, Serrano-Lopez J, Serrano J

Evolving Risk Classifications in AML in a Real-Life Scenario: After Changes upon Changes, Is It More and More Adverse?

CANCERS

DOI: 10.3390/cancers15051425

Sanchez-Garcia J, Serrano J, de La Torre EP, Serrano-Lopez J, Aparicio-Perez C, Barragan E, Montesinos P

Identifying prognostic gene panels in acute myeloid leukemia

EXPERT REVIEW OF HEMATOLOGY

DOI: 10.1080/17474086.2023.2193322

Sargas C, Ayala R, Larrayoz MJ, Chillon MC, Carrillo-Cruz E, Bilbao-Sieyro C, de la Torre EP, Martinez-Cuadron D, Rodriguez-Veiga R, Boluda B, Gil C, Bernal T, Bergua JM, Algarra L, Tormo M, Martinez-Sanchez P, Soria E, Serrano J, Alonso-Dominguez JM, Garcia-Boyero R, Amigo ML, Herrera-Puente P, Sayas MJ, Lavilla-Rubira E, Martinez-Lopez J, Calasanz MJ, Garcia-Sanz R, Perez-Simon JA, Gomez-Casares MT, Sanchez-Garcia J, Barragan E, Montesinos P

Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry

CANCERS

DOI: 10.3390/cancers15020438

Heredia G, Gonzalez-Manzanares R, Ojeda S, Molina JR, Fernandez-Aviles C, Hidalgo F, Lopez-Aguilera J, Crespin M, Mesa D, Anguita M, Castillo JC, Pan MN

Right Ventricular Function in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia: From the CTOXALL Study

CANCERS

DOI: 10.3390/cancers15215158

Lopez-Pedrera C, Oteros R, Ibáñez-Costa A, Luque-Tévar M, Muñoz-Barrera L, Barbarroja N, Chicano-Gálvez E, Marta-Enguita J, Orbe J, Velasco F, Perez-Sanchez C

The thrombus proteome in stroke reveals a key role of the innate immune system and new insights associated with its etiology, severity, and prognosis

JOURNAL OF THROMBOSIS AND HAEMOSTASIS

DOI: 10.1016/j.jtha.2023.04.015

de la Rubia J, Alonso R, Clavero ME, Askari E, Garcia A, Anton C, Fernandez M, Escalante F, Garcia A, Rios-Tamayo R, Conesa V, Bermudez MA, Merchan B, Velasco AE, Blanchard MJ, Sampol A, Gainza E, Hernandez PM, Alegre A

Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma: Results of the Compassionate Use or the Expanded Access Program in Spain

CANCERS

DOI: 10.3390/cancers15112964

Montoro MJ, Pomares H, Coll R, del Castillo TB, Tormo M, Jimenez A, Brunet S, Casano J, Oiartzabal I, Diez-Campelo M, Ramos F, Romero R, Salido-Fierrez E, Pedro C, Bargay J, Munoz-Novas C, Lopez R, Rafel M, Valcarcel D

Evaluation of the outcomes of newly diagnosed patients with high-risk myelodysplastic syndrome according to the initial therapeutical strategies chosen in usual clinical practice

LEUKEMIA & LYMPHOMA

DOI: 10.1080/10428194.2022.2154604

Moreno C, Ramos-Elbal E, Velasco P, Aguilar Y, Martinez BG, Fuentes C, Molinos A, Guerra-Garcia P, Palomo P, Verdu J, Pedroso RMA, Vagace JM, Lopez-Duarte M, Regueiro A, Tasso M, Dapena JL, Salinas JA, Navarro S, Bautista F, Lassaletta A, Lendinez F, Rives S, Pascual A, Rodriguez A, Perez-Hurtado JM, Fernandez JM, Perez-Martinez A, Gonzalez-Vicent M, de Heredia CD, Fuster JL

Haploidentical vs

HLA-matched donor hematopoietic stem-cell transplantation for pediatric patients with acute lymphoblastic leukemia in second remission: A collaborative retrospective study of the Spanish Group for Bone Marrow Transplantation in Children (GETMON/GETH) and the Spanish Childhood Relapsed ALL Board (ReALLNet)

DOI: 10.3389/fped.2023.1140637

Chumbita M, Puerta-Alcalde P, Yáñez L, Cuesta MA, Chinea A, Español-Morales I, Fernandez-Abellán P, Gudiol C, González-Sierra P, Rojas R, Sánchez-Pina JM, Vadillo IS, Sánchez M, Varela R, Vázquez L, Guerreiro M, Monzo P, Lopera C, Aiello TF, Peyrony O, Soriano A, Garcia-Vidal C

High Rate of Inappropriate Antibiotics in Patients with Hematologic Malignancies and Pseudomonas aeruginosa Bacteremia following International Guideline Recommendations

MICROBIOLOGY SPECTRUM

DOI: 10.1128/spectrum.00674-23

García-Sancho AM, Rodríguez-Pinilla SM, Domingo-Domenech E, Climent F, Sánchez-Garcia J, Jiménez JL, Piqueras MGC, Castellvi J, González AJ, de Villambrosia SG, Codina JG, Navarro B, Rodríguez G, Borrero JJ, Fraga M, Naves A, Baeza L, Córdoba R

Peripheral T-cell lymphoma with a T follicular-helper phenotype: A different entity? Results of the Spanish Real-T study

BRITISH JOURNAL OF HAEMATOLOGY

DOI: 10.1111/bjh.18941

Ramos F, Hermosín ML, Fuertes-Núñez M, Martínez P, Rodriguez-Medina C, Barrios M, Ibáñez F, Bernal T, Olave MT, Alvarez MA, Vahí M, Caballero-Velázquez T, González B, Altés A, García L, Fernández P, Durán MA, López R, Rafel M, Serrano J, Ranelletti FO

Survival Outcomes and Health-Related Quality of Life in Older Adults Diagnosed with Acute Myeloid Leukemia Receiving Frontline Therapy in Daily Practice

JOURNAL OF PERSONALIZED MEDICINE

DOI: 10.3390/jpm13121667

Berard E, Rollig C, Bertoli S, Pigneux A, Tavitian S, Kramer M, Serve H, Bornhauser M, Platzbecker U, Muller-Tidow C, Baldus CD, Martinez-Cuadron D, Serrano J, Martinez-Sanchez P, Arboli ER, Gil C, Bergua J, Bernal T, Burguera AD, Delabesse E, Bidet A, Dumas PY, Montesinos P, Recher C

BLOOD CANCER JOURNAL

2022

DOI: 10.1038/s41408-022-00700-x

Hernandez-Boluda JC, Martinez-Cuadron D, Pereira A, Rodriguez-Veiga R, Boluda B, Gil C, Casal-Marini S, Serrano J, Martinez-Lopez J, Bergua J, Algarra L, Bernal T, Lopez-Lorenzo JL, Colorado M, Lopez A, Tormo M, Sayas MJ, Trigo F, Lopez-Pavia M, Perez-Simon JA, Lavilla-Rubira E, Rodriguez-Medina C, Rodriguez-Gutierrez JI, Sanz-Caballer MA, Montesinos P

LEUKEMIA RESEARCH

2022

DOI: 10.1016/j.leukres.2022.106821

Gutierrez A, Bento L, Novelli S, Martin A, Gutierrez G, Salas MQ, Bastos-Oreiro M, Perez A, Hernani R, Viguria MC, Lopez-Godino O, Montoro J, Pinana J, Ferra C, Parody R, Martin C, Espanol I, Yanez L, Rodriguez G, Zanabili J, Herrera P, Varela M, Sampol A, Solano C, Caballero D

CANCERS

2022

DOI: 10.3390/cancers14112673

Gonzalez-Manzanares R, Castillo JC, Molina JR, Ruiz-Ortiz M, Mesa D, Ojeda S, Anguita M, Pan M

CANCERS

2022

DOI: 10.3390/cancers14061513

Labrador J, Martinez-Cuadron D, de la Fuente A, Rodriguez-Veiga R, Serrano J, Tormo M, Rodriguez-Arboli E, Ramos F, Bernal T, Lopez-Pavia M, Trigo F, Martinez-Sanchez MP, Rodriguez-Gutierrez JI, Rodriguez-Medina C, Gil C, Belmonte DG, Vives S, Foncillas MA, Perez-Encinas M, Novo A, Recio I, Rodriguez-Macias G, Bergua JM, Noriega V, Lavilla E, Roldan-Perez A, Sanz MA, Montesinos P

CANCERS

2022

DOI: 10.3390/cancers14092342

Martinez-Cuadron D, Serrano J, Mariz J, Gil C, Tormo M, Martinez-Sanchez P, Rodriguez-Arboli E, Garcia-Boyero R, Rodriguez-Medina C, Martinez-Chamorro C, Polo M, Bergua J, Aguiar E, Amigo ML, Herrera P, Alonso-Dominguez JM, Bernal T, Espadana A, Sayas MJ, Algarra L, Vidriales MB, Vasconcelos G, Vives S, Perez-Encinas MM, Lopez A, Noriega V, Garcia-Fortes M, Chillon MC, Rodriguez-Gutierrez JI, Calasanz MJ, Labrador J, Lopez JA, Boluda B, Rodriguez-Veiga R, Martinez-Lopez J, Barragan E, Sanz MA, Montesinos P

CANCERS

2022

DOI: 10.3390/cancers14112817

Albasanz-Puig A, Dura-Miralles X, Laporte-Amargos J, Mussetti A, Ruiz-Camps I, Puerta-Alcalde P, Abdala E, Oltolini C, Akova M, Montejo JM, Mikulska M, Martin-Davila P, Herrera F, Gasch O, Drgona L, Morales HMP, Brunel AS, Garcia E, Isler B, Kern WV, Retamar-Gentil P, Aguado JM, Montero M, Kanj SS, Sipahi OR, Calik S, Marquez-Gomez I, Marin JI, Gomes MZR, Hemmati P, Araos R, Peghin M, del Pozo JL, Yanez L, Tilley R, Manzur A, Novo A, Pallares N, Bergas A, Carratala J, Gudiol C

MICROORGANISMS

2022

DOI: 10.3390/microorganisms10040733

Gomez VG, Regano LD, Villa AR, Rubio CD, Vicent MG, Serra IB, Fernandez JM, Martinez AIP, Hurtado JMP, Duarte ML, Regalado MSM, Perez-Martinez A

ANALES DE PEDIATRIA

2022

DOI: 10.1016/j.anpedi.2021.02.015

Lopez JS, Jimenez-Jimenez C, Chutipongtanate S, Serrano J, Rodriguez-Moreno M, Jimenez A, Jimenez Y, Pedrero SG, Lainez D, Alonso-Dominguez JM, Sillero PL, Piris MA, Sanchez-Garcia J

LEUKEMIA & LYMPHOMA

2022

DOI: 10.1080/10428194.2022.2056173

Sancho JM, Marin-Niebla A, Fernandez S, Capote FJ, Canigral C, Grande C, Donato E, Zeberio I, Puerta JM, Rivas A, Perez-Ceballos E, Vale A, Garcia-Sancho AM, Salar A, Gonzalez-Barca E, Teruel A, Pastoriza C, Conde-Royo D, Sanchez-Garcia J, Barrenetxea C, Arranz R, Hernandez-Rivas JA, Ramirez MJ, Jimenez A, Rubio-Azpeitia E

INTERNATIONAL JOURNAL OF HEMATOLOGY

2022

DOI: 10.1007/s12185-022-03367-z

Ayala R, Carreno-Tarragona G, Barragan E, Boluda B, Larrayoz MJ, Chillon MC, Carrillo-Cruz E, Bilbao C, Sanchez-Garcia J, Bernal T, Martinez-Cuadron D, Gil C, Serrano J, Rodriguez-Medina C, Bergua J, Perez-Simon JA, Calbacho M, Alonso-Dominguez JM, Labrador J, Tormo M, Amigo ML, Herrera-Puente P, Rapado I, Sargas C, Vazquez I, Calasanz MJ, Gomez-Casares T, Garcia-Sanz R, Sanz MA, Martinez-Lopez J, Montesinos P

CANCERS

2022

DOI: 10.3390/cancers14235799

Recher C, Rollig C, Berard E, Bertoli S, Dumas PY, Tavitian S, Kramer M, Serve H, Bornhauser M, Platzbecker U, Muller-Tidow C, Baldus CD, Martinez-Cuadron D, Serrano J, Martinez-Sanchez P, Arboli ER, Gil C, Bergua J, Bernal T, Burguera AD, Delabesse E, Bidet A, Pigneux A, Montesinos P

LEUKEMIA

2022

DOI: 10.1038/s41375-021-01425-9

Macias-Sanchez MD, Morata-Tarifa C, Cuende N, Cardesa-Gil A, Cuesta-Casas MA, Pascual-Cascon MJ, Pascual A, Martin-Calvo C, Jurado M, Perez-Simon JA, Espigado I, Lopez SG, Sanchez GC, Mata-Alcazar-Caballero R, Sanchez-Pernaute R

STEM CELLS TRANSLATIONAL MEDICINE

2022

DOI: 10.1093/stcltm/szac003

Castano-Bonilla T, Barragan E, Sargas C, Sanz A, Algarra L, Herrera-Puente P, Garcia-Boyero R, Barrios M, Martinez-Cuadron D, Rodriguez-Veiga R, Boluda B, Gil C, Serrano-Lopez J, Martinez-Lopez J, Sayas-Lloris MJ, Olave MT, Riaza-Grau R, Bernal-Del Castillo T, Larrayoz MJ, Amigo R, Jimenez-Velasco A, Sanchez J, Ayala R, Blas C, Lainez D, Serrano-Lopez J, Sanz MA, Alonso-Dominguez JM, Montesinos P

DISEASE MARKERS

2022

DOI: 10.1155/2022/3132941

Vilorio-Marques L, Fernandez CC, Mora E, Gutierrez L, Bua BR, Lorenzo MJJ, Beya MD, Pampliega MV, Molero A, Sanchez-Garcia J, Calabuig M, Cedena MT, Chen-Liang T, Santa JAD, Padilla I, Hernandez F, Diez R, Asensi P, Xicoy B, Sanz G, Valcarcel D, Diez-Campelo M, Bernal T

THERAPEUTIC ADVANCES IN HEMATOLOGY

2022

DOI: 10.1177/20406207221127547

Chumbita M, Puerta-Alcalde P, Yanez L, Cuesta MA, Chinea A, Morales IE, Abellan PF, Gudiol C, Guerreiro M, Gonzalez-Sierra P, Rojas R, Pina JMS, Vadillo IS, Varela R, Vazquez L, Lopera C, Monzo P, Garcia-Vidal C

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

2022

DOI: 10.1093/jac/dkac135

Villar S, Ariceta B, Agirre X, Urribarri AD, Ayala R, Martinez-Cuadron D, Bergua JM, Vives S, Algarra L, Tormo M, Martinez P, Serrano J, Simoes C, Herrera P, Calasanz MJ, Alfonso-Pierola A, Paiva B, Martinez-Lopez J, San Miguel JF, Prosper F, Montesinos P

FRONTIERS IN ONCOLOGY

2022

DOI: 10.3389/fonc.2022.1054458

Martinez-Cuadron D, Megias-Vericat JE, Serrano J, Martinez-Sanchez P, Rodriguez-Arboli E, Gil C, Aguiar E, Bergua J, Lopez-Lorenzo JL, Bernal T, Espadana A, Colorado M, Rodriguez-Medina C, Lopez-Pavia M, Tormo M, Algarra L, Amigo ML, Sayas MJ, Labrador J, Rodriguez-Gutierrez JI, Benavente C, Costilla-Barriga L, Garcia-Boyero R, Lavilla-Rubira E, Vives S, Herrera P, Garcia-Belmonte D, Herraez MM, Esteves GV, Gomez-Roncero MI, Cabello A, Bautista G, Balerdi A, Mariz J, Boluda B, Sanz MA, Montesinos P

BLOOD ADVANCES

2022

DOI: 10.1182/bloodadvances.2021005335

Ruiz-Llobet A, Gassiot S, Sarrate E, Zubicaray J, Dapena JL, Rives S, Sevilla J, Lopez AM, Romero MP, Montoya C, Vagace JM, Hurtado JRM, Garcia-Morin M, Abos MG, Sanchez MCM, Lendinez F, Moraleda PP, Tallon M, Gonzalez B, Urrutia E, Serna JV, Pleguezuelos IP, Merino MM, Elbal ER, Orellana E, Munoz HB, Berrueco R

JOURNAL OF THROMBOSIS AND HAEMOSTASIS

2022

DOI: 10.1111/jth.15699

Perez-Sanchez L, Patino-Trives AM, Aguirre-Zamorano MA, Luque-Tevar M, Abalos-Aguilera MC, Arias-de La Rosa I, Segui P, Velasco-Gimena F, Barbarroja N, Escudero-Contreras A, Collantes-Estevez E, Perez-Sanchez C, Lopez-Pedrera C

Characterization of Antiphospholipid Syndrome Atherothrombotic Risk by Unsupervised Integrated Transcriptomic Analyses

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

DOI: 10.1161/ATVBAHA.120.315346

IF: 8,311 Q1 D1

Vives S, Martinez-Cuadron D, Burgues JB, Algarra L, Tormo M, Martinez-Sanchez MP, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Lopez-Lorenzo JL, Gil C, Vidriales B, Falantes JF, Serrano A, Labrador J, Sayas MJ, Foncillas MA, Barciela MLA, Olave MT, Colorado M, Gascon A, Fernandez MA, Simiele A, Perez-Encinas MM, Rodriguez-Veiga R, Garcia O, Martinez-Lopez J, Barragan E, Paiva B, Sanz MA, Montesinos P

A phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia

CANCER

DOI: 10.1002/cncr.33403

IF: 6,86 Q1 D2

Bento L, Gutierrez A, Novelli S, Montoro J, Pinana JL, Lopez-Corral L, Cabrero M, Martin-Sancho A, Gutierrez-Garcia G, Ortiz-Moscovich M, Bastos-Oreiro M, Dorado N, Perez A, Hernani R, Ferra C, Parody R, Garcia-Cadenas I, Herrera P, Rodriguez G, Rodriguez N, Martin C, Yanez L, Zanabili J, Varela MR, Lopez-Godino O, Heras I, Espanol I, Martinez C, Perez-Simon JA, Solano C, Sureda A, Sierra J, Sampol A, Caballero D

Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study

BONE MARROW TRANSPLANTATION

DOI: 10.1038/s41409-021-01264-

IF: 5,483 Q1 D3

Palanques-Pastor T, Megias-Vericat JE, Martinez P, Lorenzo JLL, Navascues JC, Macias GR, Cano I, Sangerman MA, Vicente MBV, Algarra JLA, Foncillas MA, Herrera P, Prieto CB, Vives S, Alvarez AF, Palomares LC, Sobas M, Gonzalo AC, Garcia RC, Diez MEA, Llorente DD, Elorza BN, Burgues JMB, Del Castillo TB, Rodriguez MCM, Lopez ED, Villegas ACF, Boyero RG, Escobar CE, Merino CS, Cervero C, Perez AR, Ramos LH, Calvo MC, Olave MT, Gutierrez PV, de Laiglesiai A, Serrano J, Irazu MJN, Pinana JL, Sanz MA, Martinez-Lopez J, Montesinos P

Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group

LEUKEMIA & LYMPHOMA

DOI: 10.1080/10428192021.1948031

IF: 3,28 Q3

Ribera JM, Morgades M, Ciudad J, Montesinos P, Esteve J, Genesca E, Barba P, Ribera J, Garcia-Cadenas I, Moreno MJ, Martinez-Carballeira D, Torrent A, Martinez-Sanchez P, Monsalvo S, Gil C, Tormo M, Artola MT, Cervera M, Gonzalez-Campos J, Rodriguez C, Bermudez A, Novo A, Soria B, Coll R, Amigo ML, Lopez-Martinez A, Fernandez-Martin R, Serrano J, Mercadal S, Cladera A, Gimenez-Conca A, Penarrubia MJ, Abella E, Vall-llovera F, Hernandez-Rivas JM, Garcia-Guinon A, Bergua JM, de Rueda B, Sanchez-Sanchez MJ, Serrano A, Calbacho M, Alonso N, Mendez-Sanchez JA, Garcia-Boyero R, Olivares M, Barrena S, Zamora L, Granada I, Lhermitte L, Feliu E, Orfao A

Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome-negative adult lymphoblastic leukemia

BLOOD

DOI: 10.1182/blood.2020007311

IF: 22,113 Q1 D1

Rodriguez-Pinilla SM, Domingo-Domenech E, Climent F, Sanchez J, Seoane CP, Jimenez JL, Garcia-Cosio M, Caballero D, Munez OJB, Carpio C, Castellvi J, Pozo AM, Farre BG, Bendana A, Aliste C, Gonzalez AJ, de Villambrosia SG, Piris MA, Codina JG, Mayordomo-Aranda E, Navarro B, Bellas C, Rodriguez G, Borrero JJ, Ruiz-Zorrilla A, Grande M, Montoto C, Cordoba R

Clinical and pathological characteristics of peripheral T-cell lymphomas in a Spanish population: a retrospective study

BRITISH JOURNAL OF HAEMATOLOGY

DOI: 10.1111/bjh.16741

IF: 6,998 Q1 D2

Solano C, Vazquez L, Gimenez E, de la Camara R, Albert E, Rovira M, Espigado I, Calvo CM, Lopez-Jimenez J, Suarez-Lledo M, Chinea A, Esquirol A, Perez A, Bermudez A, Saldana R, Heras I, Gonzalez-Huerta AJ, Torrado T, Batlle M, Jimenez S, Vallejo C, Barba P, Cuesta MA, Pinana JL, Navarro D

Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment

BONE MARROW TRANSPLANTATION

DOI: 10.1038/s41409-020-01157-x

IF: 5,483 Q1 D3

Janusz K, Izquierdo MM, Cadenas FL, Ramos F, Sanchez JMH, Lumbreras E, Robledo C, del Real JS, Caballero JC, Collado R, Bernal T, Pedro C, Insunza A, de Paz R, Xicoy B, Salido E, Garcia JS, Minguez SS, Garcia CM, Munoz AMS, Barba MS, Rivas JMH, Abaigar M, Campelo MD

Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients

ANNALS OF HEMATOLOGY

DOI: 10.1007/s00277-020-04360-4

IF: 3,673 Q2 D5

Rodriguez DC, Urain TA, Rodriguez AC, Torres EG, Vicent MG, Garcia GG, Garcia AR, Hidalgo MC, Villacampa A

Cost-effectiveness analysis of defibrotide in the treatment of patients with severe veno-occlusive disease/sinusoidal obstructive syndrome with multiorgan dysfunction following hematopoietic cell transplantation in Spain

JOURNAL OF MEDICAL ECONOMICS

DOI: 10.1080/13696998.2021.191674

IF: 2,448 Q2 D5

Vicent MG, de Heredia CD, de Pablo JG, Molina B, Regueiro A, Martinez AP, Palomo P, Corral LL, Garcia E, Fernandez JM, Perez A, Jimenez MJ, Guerreiro M, Vallejo C, Gallardo AI, Lopez O, Benito A, Marsal J, Duarte M, Bento L, Badell I, Pedraza A, Ubieto AJ, Gonzalez P, Centurion IG, Costilla L, Belendez C, Esquirol A, Espigado I, Lavilla E, Diaz MA

Defibrotide in hematopoietic stem cell transplantation: A multicenter survey study of the Spanish Hematopoietic Stem Cell Transplantation Group (GETH)

EUROPEAN JOURNAL OF HAEMATOLOGY

DOI: 1111/ejh.13618

Martinez-Cuadron D, Serrano J, Gil C, Tormo M, Martinez-Sanchez P, Perez-Simon JA, Garcia-Boyero R, Rodriguez-Medina C, Lopez-Pavia M, Benavente C, Bergua J, Lavilla-Rubira E, Amigo ML, Herrera P, Alonso-Dominguez JM, Bernal T, Colorado M, Sayas MJ, Algarra L, Vidriales MB, Rodriguez-Macias G, Vives S, Perez-Encinas MM, Lopez A, Noriega V, Garcia-Fortes M, Ramos F, Rodriguez-Gutierrez JI, Costilla-Barriga L, Labrador J, Boluda B, Rodriguez-Veiga R, Martinez-Lopez J, Sanz MA, Montesinos P

Evolving treatment patterns and outcomes in older patients (>= 60 years) with AML: changing everything to change nothing?

LEUKEMIA

DOI: 10.1038/s41375-020-01058-4

IF: 11,528 Q1 D1

Paiva B, Vidriales MB, Sempere A, Tarin F, Colado E, Benavente C, Cedena MT, Sanchez J, Caballero-Velazquez T, Cordon L, Garces JJ, Simoes C, Martinez-Cuadron D, Bernal T, Botella C, Grille S, Serrano J, Rodriguez-Medina C, Algarra L, Alonso-Dominguez JM, Amigo ML, Barrios M, Garcia-Boyero R, Colorado M, Perez-Oteyza J, Perez-Encinas M, Costilla-Barriga L, Sayas MJ, Perez O, Gonzalez-Diaz M, Perez-Simon JA, Martinez-Lopez J, Sossa C, Orfao A, San Miguel JF, Sanz MA, Montesinos P

Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia

LEUKEMIA

DOI: 10.1038/s41375-021-01126-3

IF: 11,528 Q1 D1

Serrano-Lopez J, Hegde S, Kumar S, Serrano J, Fang J, Wellendorf AM, Roche PA, Rangel Y, Carrington LJ, Geiger H, Grimes HL, Luther S, Maillard I, Sanchez-Garcia J, Starczynowski DT, Cancelas JA

Inflammation rapidly recruits mammalian GMP and MDP from bone marrow into regional lymphatics

ELIFE

DOI: 10.7554/eLife.66190

IF: 8,14 Q1 D1

Mingot-Castellano ME, Pardos-Gea J, Haya S, Bastida-Bermejo JM, Tassies D, Marco-Rico A, Nunez R, Garcia-Candel F, De Mora MCFS, Soto I, Alvarez-Roman MT, Asenjo S, Carrasco M, Lluch-Garcia R, Martin-Antoran JM, Rodriguez-Alen A, Rosello E, Torres-Minana L, Marcellini-Antonio S, Moreto-Quinana A, Rodriguez-Garcia JA, Aguinaco-Culebras R, Alonso-Escobar N, Cervero-Santiago C, Fernandez-Mosteirin N, Martinez-Badas MP, Perez-Sanchez M, Perez-Montes R, Rodriguez-Gonzalez R, Uribe-Barrientos M, Caparros-Miranda IS, Iglesias-Fernandez M, Baena A, Rodriguez-Lopez M, Sebrango-Sandia A, Vazquez-Fernandez I, Marco P

Management of acquired hemophilia A: results from the Spanish registry

BLOOD ADVANCES

DOI: 10.1182/bloodadvances.2021004626

IF: 6,799 Q1 D2

Vega-Garcia N, Perez-Jaume S, Esperanza-Cebollada E, Vicente-Garces C, Torrebadell M, Jimenez-Velasco A, Ortega M, Llop M, Abad L, Vagace JM, Minguela A, Pratcorona M, Sanchez-Garcia J, Garcia-Calderon CB, Gomez-Casares MT, Martin-Clavero E, Escudero A, Martinez-Gallo MR, Munoz L, Velasco MR, Garcia-Morin M, Catala A, Pascual A, Velasco P, Fernandez JM, Lassaletta A, Fuster JL, Badell I, Molinos-Quintana A, Molines A, Guerra-Garcia P, Perez-Martinez A, Garcia-Abos M, Ortiz RR, Pisa S, Adan R, de Heredia CD, Dapena JL, Rives S, Ramirez-Orellana M, Camos M

Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment

FRONTIERS IN PEDIATRICS

DOI: 10.3389/fped.2020.614521

IF: 3,418 Q1 D2

Simoes C, Paiva B, Martinez-Cuadron D, Bergua JM, Vives S, Algarra L, Tormo M, Martinez P, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Gil C, Lopez JL, Vidriales MB, Labrador J, Falantes JF, Sayas MJ, Ayala R, Martinez-Lopez J, Villar S, Calasanz MJ, Prosper F, San-Miguel JF, Sanz MA, Montesinos P

Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial

BLOOD ADVANCES

DOI: 10.1182/bloodadvances.2020003195

Sargas C, Ayala R, Chillon MC, Larrayoz MJ, Carrillo-Cruz E, Bilbao C, Yebenes-Ramirez M, Llop M, Rapado I, Garcia-Sanz R, Vazquez I, Soria E, Florido-Ortega Y, Janusz K, Botella C, Serrano J, Martinez-Cuadron D, Bergua J, Amigo ML, Martinez-Sanchez P, Tormo M, Bernal T, Herrera-Puente P, Garcia R, Algarra L, Sayas MJ, Costilla-Barriga L, Perez-Santolalla E, Marchante I, Lavilla-Rubira E, Noriega V, Alonso-Dominguez JM, Sanz MA, Sanchez-Garcia J, Gomez-Casares MT, Perez-Simon JA, Calasanz MJ, Gonzalez-Diaz M, Martinez-Lopez J, Barragan E, Montesinos P

Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project

HAEMATOLOGICA

DOI: 10.3324/haematol.2020.263806

IF: 9,941 Q1 D2

Castano-Bonilla T, Alonso-Dominguez JM, Barragan E, Rodriguez-Veiga R, Sargas C, Gil C, Chillon C, Vidriales MB, Garcia R, Martinez-Lopez J, Ayala R, Larrayoz MJ, Anguita E, Cuello R, Cantalapiedra A, Carrillo E, Soria-Saldise E, Labrador J, Recio I, Algarra L, Rodriguez-Medina C, Bilbao-Syeiro C, Lopez-Lopez JA, Serrano J, De Cabo E, Sayas MJ, Olave MT, Sanchez-Garcia J, Mateos M, Blas C, Lopez-Lorenzo JL, Lainez-Gonzalez D, Serrano J, Martinez-Cuadron D, Sanz MA, Montesinos P

Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens

SCIENTIFIC REPORTS

DOI: 10.1038/s41598-021-00050-x

IF: 4,38 Q1 D3

Abrisqueta P, Loscertales J, Terol MJ, Payer AR, Ortiz M, Perez I, Cuellar-Garcia C, de la Mata MF, Rodriguez A, Lario A, Delgado J, Godoy A, Perez JMA, Berruezo MJ, Oliveira A, Hernandez-Rivas JA, Malo MDG, Medina A, Martin PG, Osorio S, Baltasar P, Fernandez-Zarzoso M, Marco F, Mancenido MJV, Simonovich AS, Rubio ML, Jarque I, Suarez A, Alvarez RF, Anchel AL, Rios E, Castillo MDL, Persona EP, Munoz RG, Ramos R, Yanez L, Bello JL, Loriente C, Acha D, Villanueva M

Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study)

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

DOI: 10.1016/j.clml.2021.07.022

IF: 3,231 Q3

Murillo-Sanjuan L, Gonzalez-Vicent M, Aparicio BA, Serra IB, Villa AR, Oficialdegui MLU, Lopez-Duarte M, Belendez-Bieler C, Urgelles AS, Navarro JS, Diaz-de-Heredia C

Survival and toxicity outcomes of hematopoietic stem cell transplantation for pediatric patients with Fanconi anemia: a unified multicentric national study from the Spanish Working Group for Bone Marrow Transplantation in Children

BONE MARROW TRANSPLANTATION

DOI: 10.1038/s41409-020-01172-y

Ayala R, Rapado I, Onecha E, Martinez-Cuadron D, Carreno-Tarragona G, Bergua JM, Vives S, Algarra JL, Tormo M, Martinez P, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Gil C, Lorenzo JLL, Vidriales MB, Labrador J, Falantes JF, Sayas MJ, Paiva B, Barragan E, Prosper F, Sanz MA, Martinez-Lopez J, Montesinos P

The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial

CANCERS

DOI: 10.3390/cancers13102458

IF: 6,639 Q1 D3

Perez-Sanchez L, Patino-Trives AM, Aguirre-Zamorano MA, Luque-Tevar M, Abalos-Aguilera MC, Arias-de La Rosa I, Segui P, Velasco-Gimena F, Barbarroja N, Escudero-Contreras A, Collantes-Estevez E, Perez-Sanchez C, Lopez-Pedrera C

Characterization of Antiphospholipid Syndrome Atherothrombotic Risk by Unsupervised Integrated Transcriptomic Analyses

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

DOI: 10.1161/ATVBAHA.120.315346

IF: 8,311 Q1 D1

Vives S, Martinez-Cuadron D, Burgues JB, Algarra L, Tormo M, Martinez-Sanchez MP, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Lopez-Lorenzo JL, Gil C, Vidriales B, Falantes JF, Serrano A, Labrador J, Sayas MJ, Foncillas MA, Barciela MLA, Olave MT, Colorado M, Gascon A, Fernandez MA, Simiele A, Perez-Encinas MM, Rodriguez-Veiga R, Garcia O, Martinez-Lopez J, Barragan E, Paiva B, Sanz MA, Montesinos P

A phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia

CANCER

DOI: 10.1002/cncr.33403

IF: 6,86 Q1 D2

Bento L, Gutierrez A, Novelli S, Montoro J, Pinana JL, Lopez-Corral L, Cabrero M, Martin-Sancho A, Gutierrez-Garcia G, Ortiz-Moscovich M, Bastos-Oreiro M, Dorado N, Perez A, Hernani R, Ferra C, Parody R, Garcia-Cadenas I, Herrera P, Rodriguez G, Rodriguez N, Martin C, Yanez L, Zanabili J, Varela MR, Lopez-Godino O, Heras I, Espanol I, Martinez C, Perez-Simon JA, Solano C, Sureda A, Sierra J, Sampol A, Caballero D

Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study

BONE MARROW TRANSPLANTATION

DOI: 10.1038/s41409-021-01264-

IF: 5,483 Q1 D3

Palanques-Pastor T, Megias-Vericat JE, Martinez P, Lorenzo JLL, Navascues JC, Macias GR, Cano I, Sangerman MA, Vicente MBV, Algarra JLA, Foncillas MA, Herrera P, Prieto CB, Vives S, Alvarez AF, Palomares LC, Sobas M, Gonzalo AC, Garcia RC, Diez MEA, Llorente DD, Elorza BN, Burgues JMB, Del Castillo TB, Rodriguez MCM, Lopez ED, Villegas ACF, Boyero RG, Escobar CE, Merino CS, Cervero C, Perez AR, Ramos LH, Calvo MC, Olave MT, Gutierrez PV, de Laiglesiai A, Serrano J, Irazu MJN, Pinana JL, Sanz MA, Martinez-Lopez J, Montesinos P

Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group

LEUKEMIA & LYMPHOMA

DOI: 10.1080/10428192021.1948031

IF: 3,28 Q3

Ribera JM, Morgades M, Ciudad J, Montesinos P, Esteve J, Genesca E, Barba P, Ribera J, Garcia-Cadenas I, Moreno MJ, Martinez-Carballeira D, Torrent A, Martinez-Sanchez P, Monsalvo S, Gil C, Tormo M, Artola MT, Cervera M, Gonzalez-Campos J, Rodriguez C, Bermudez A, Novo A, Soria B, Coll R, Amigo ML, Lopez-Martinez A, Fernandez-Martin R, Serrano J, Mercadal S, Cladera A, Gimenez-Conca A, Penarrubia MJ, Abella E, Vall-llovera F, Hernandez-Rivas JM, Garcia-Guinon A, Bergua JM, de Rueda B, Sanchez-Sanchez MJ, Serrano A, Calbacho M, Alonso N, Mendez-Sanchez JA, Garcia-Boyero R, Olivares M, Barrena S, Zamora L, Granada I, Lhermitte L, Feliu E, Orfao A

Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome-negative adult lymphoblastic leukemia

BLOOD

DOI: 10.1182/blood.2020007311

IF: 22,113 Q1 D1

Rodriguez-Pinilla SM, Domingo-Domenech E, Climent F, Sanchez J, Seoane CP, Jimenez JL, Garcia-Cosio M, Caballero D, Munez OJB, Carpio C, Castellvi J, Pozo AM, Farre BG, Bendana A, Aliste C, Gonzalez AJ, de Villambrosia SG, Piris MA, Codina JG, Mayordomo-Aranda E, Navarro B, Bellas C, Rodriguez G, Borrero JJ, Ruiz-Zorrilla A, Grande M, Montoto C, Cordoba R

Clinical and pathological characteristics of peripheral T-cell lymphomas in a Spanish population: a retrospective study

BRITISH JOURNAL OF HAEMATOLOGY

DOI: 10.1111/bjh.16741

IF: 6,998 Q1 D2

Solano C, Vazquez L, Gimenez E, de la Camara R, Albert E, Rovira M, Espigado I, Calvo CM, Lopez-Jimenez J, Suarez-Lledo M, Chinea A, Esquirol A, Perez A, Bermudez A, Saldana R, Heras I, Gonzalez-Huerta AJ, Torrado T, Batlle M, Jimenez S, Vallejo C, Barba P, Cuesta MA, Pinana JL, Navarro D

Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment

BONE MARROW TRANSPLANTATION

DOI: 10.1038/s41409-020-01157-x

IF: 5,483 Q1 D3

Janusz K, Izquierdo MM, Cadenas FL, Ramos F, Sanchez JMH, Lumbreras E, Robledo C, del Real JS, Caballero JC, Collado R, Bernal T, Pedro C, Insunza A, de Paz R, Xicoy B, Salido E, Garcia JS, Minguez SS, Garcia CM, Munoz AMS, Barba MS, Rivas JMH, Abaigar M, Campelo MD

Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients

ANNALS OF HEMATOLOGY

DOI: 10.1007/s00277-020-04360-4

IF: 3,673 Q2 D5

Rodriguez DC, Urain TA, Rodriguez AC, Torres EG, Vicent MG, Garcia GG, Garcia AR, Hidalgo MC, Villacampa A

Cost-effectiveness analysis of defibrotide in the treatment of patients with severe veno-occlusive disease/sinusoidal obstructive syndrome with multiorgan dysfunction following hematopoietic cell transplantation in Spain

JOURNAL OF MEDICAL ECONOMICS

DOI: 10.1080/13696998.2021.191674

IF: 2,448 Q2 D5

Vicent MG, de Heredia CD, de Pablo JG, Molina B, Regueiro A, Martinez AP, Palomo P, Corral LL, Garcia E, Fernandez JM, Perez A, Jimenez MJ, Guerreiro M, Vallejo C, Gallardo AI, Lopez O, Benito A, Marsal J, Duarte M, Bento L, Badell I, Pedraza A, Ubieto AJ, Gonzalez P, Centurion IG, Costilla L, Belendez C, Esquirol A, Espigado I, Lavilla E, Diaz MA

Defibrotide in hematopoietic stem cell transplantation: A multicenter survey study of the Spanish Hematopoietic Stem Cell Transplantation Group (GETH)

EUROPEAN JOURNAL OF HAEMATOLOGY

DOI: 1111/ejh.13618

Martinez-Cuadron D, Serrano J, Gil C, Tormo M, Martinez-Sanchez P, Perez-Simon JA, Garcia-Boyero R, Rodriguez-Medina C, Lopez-Pavia M, Benavente C, Bergua J, Lavilla-Rubira E, Amigo ML, Herrera P, Alonso-Dominguez JM, Bernal T, Colorado M, Sayas MJ, Algarra L, Vidriales MB, Rodriguez-Macias G, Vives S, Perez-Encinas MM, Lopez A, Noriega V, Garcia-Fortes M, Ramos F, Rodriguez-Gutierrez JI, Costilla-Barriga L, Labrador J, Boluda B, Rodriguez-Veiga R, Martinez-Lopez J, Sanz MA, Montesinos P

Evolving treatment patterns and outcomes in older patients (>= 60 years) with AML: changing everything to change nothing?

LEUKEMIA

DOI: 10.1038/s41375-020-01058-4

IF: 11,528 Q1 D1

Paiva B, Vidriales MB, Sempere A, Tarin F, Colado E, Benavente C, Cedena MT, Sanchez J, Caballero-Velazquez T, Cordon L, Garces JJ, Simoes C, Martinez-Cuadron D, Bernal T, Botella C, Grille S, Serrano J, Rodriguez-Medina C, Algarra L, Alonso-Dominguez JM, Amigo ML, Barrios M, Garcia-Boyero R, Colorado M, Perez-Oteyza J, Perez-Encinas M, Costilla-Barriga L, Sayas MJ, Perez O, Gonzalez-Diaz M, Perez-Simon JA, Martinez-Lopez J, Sossa C, Orfao A, San Miguel JF, Sanz MA, Montesinos P

Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia

LEUKEMIA

DOI: 10.1038/s41375-021-01126-3

IF: 11,528 Q1 D1

Serrano-Lopez J, Hegde S, Kumar S, Serrano J, Fang J, Wellendorf AM, Roche PA, Rangel Y, Carrington LJ, Geiger H, Grimes HL, Luther S, Maillard I, Sanchez-Garcia J, Starczynowski DT, Cancelas JA

Inflammation rapidly recruits mammalian GMP and MDP from bone marrow into regional lymphatics

ELIFE

DOI: 10.7554/eLife.66190

IF: 8,14 Q1 D1

Mingot-Castellano ME, Pardos-Gea J, Haya S, Bastida-Bermejo JM, Tassies D, Marco-Rico A, Nunez R, Garcia-Candel F, De Mora MCFS, Soto I, Alvarez-Roman MT, Asenjo S, Carrasco M, Lluch-Garcia R, Martin-Antoran JM, Rodriguez-Alen A, Rosello E, Torres-Minana L, Marcellini-Antonio S, Moreto-Quinana A, Rodriguez-Garcia JA, Aguinaco-Culebras R, Alonso-Escobar N, Cervero-Santiago C, Fernandez-Mosteirin N, Martinez-Badas MP, Perez-Sanchez M, Perez-Montes R, Rodriguez-Gonzalez R, Uribe-Barrientos M, Caparros-Miranda IS, Iglesias-Fernandez M, Baena A, Rodriguez-Lopez M, Sebrango-Sandia A, Vazquez-Fernandez I, Marco P

Management of acquired hemophilia A: results from the Spanish registry

BLOOD ADVANCES

DOI: 10.1182/bloodadvances.2021004626

IF: 6,799 Q1 D2

Vega-Garcia N, Perez-Jaume S, Esperanza-Cebollada E, Vicente-Garces C, Torrebadell M, Jimenez-Velasco A, Ortega M, Llop M, Abad L, Vagace JM, Minguela A, Pratcorona M, Sanchez-Garcia J, Garcia-Calderon CB, Gomez-Casares MT, Martin-Clavero E, Escudero A, Martinez-Gallo MR, Munoz L, Velasco MR, Garcia-Morin M, Catala A, Pascual A, Velasco P, Fernandez JM, Lassaletta A, Fuster JL, Badell I, Molinos-Quintana A, Molines A, Guerra-Garcia P, Perez-Martinez A, Garcia-Abos M, Ortiz RR, Pisa S, Adan R, de Heredia CD, Dapena JL, Rives S, Ramirez-Orellana M, Camos M

Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment

FRONTIERS IN PEDIATRICS

DOI: 10.3389/fped.2020.614521

IF: 3,418 Q1 D2

Simoes C, Paiva B, Martinez-Cuadron D, Bergua JM, Vives S, Algarra L, Tormo M, Martinez P, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Gil C, Lopez JL, Vidriales MB, Labrador J, Falantes JF, Sayas MJ, Ayala R, Martinez-Lopez J, Villar S, Calasanz MJ, Prosper F, San-Miguel JF, Sanz MA, Montesinos P

Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial

BLOOD ADVANCES

DOI: 10.1182/bloodadvances.2020003195

Sargas C, Ayala R, Chillon MC, Larrayoz MJ, Carrillo-Cruz E, Bilbao C, Yebenes-Ramirez M, Llop M, Rapado I, Garcia-Sanz R, Vazquez I, Soria E, Florido-Ortega Y, Janusz K, Botella C, Serrano J, Martinez-Cuadron D, Bergua J, Amigo ML, Martinez-Sanchez P, Tormo M, Bernal T, Herrera-Puente P, Garcia R, Algarra L, Sayas MJ, Costilla-Barriga L, Perez-Santolalla E, Marchante I, Lavilla-Rubira E, Noriega V, Alonso-Dominguez JM, Sanz MA, Sanchez-Garcia J, Gomez-Casares MT, Perez-Simon JA, Calasanz MJ, Gonzalez-Diaz M, Martinez-Lopez J, Barragan E, Montesinos P

Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project

HAEMATOLOGICA

DOI: 10.3324/haematol.2020.263806

IF: 9,941 Q1 D2

Castano-Bonilla T, Alonso-Dominguez JM, Barragan E, Rodriguez-Veiga R, Sargas C, Gil C, Chillon C, Vidriales MB, Garcia R, Martinez-Lopez J, Ayala R, Larrayoz MJ, Anguita E, Cuello R, Cantalapiedra A, Carrillo E, Soria-Saldise E, Labrador J, Recio I, Algarra L, Rodriguez-Medina C, Bilbao-Syeiro C, Lopez-Lopez JA, Serrano J, De Cabo E, Sayas MJ, Olave MT, Sanchez-Garcia J, Mateos M, Blas C, Lopez-Lorenzo JL, Lainez-Gonzalez D, Serrano J, Martinez-Cuadron D, Sanz MA, Montesinos P

Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens

SCIENTIFIC REPORTS

DOI: 10.1038/s41598-021-00050-x

IF: 4,38 Q1 D3

Abrisqueta P, Loscertales J, Terol MJ, Payer AR, Ortiz M, Perez I, Cuellar-Garcia C, de la Mata MF, Rodriguez A, Lario A, Delgado J, Godoy A, Perez JMA, Berruezo MJ, Oliveira A, Hernandez-Rivas JA, Malo MDG, Medina A, Martin PG, Osorio S, Baltasar P, Fernandez-Zarzoso M, Marco F, Mancenido MJV, Simonovich AS, Rubio ML, Jarque I, Suarez A, Alvarez RF, Anchel AL, Rios E, Castillo MDL, Persona EP, Munoz RG, Ramos R, Yanez L, Bello JL, Loriente C, Acha D, Villanueva M

Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study)

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

DOI: 10.1016/j.clml.2021.07.022

IF: 3,231 Q3

Murillo-Sanjuan L, Gonzalez-Vicent M, Aparicio BA, Serra IB, Villa AR, Oficialdegui MLU, Lopez-Duarte M, Belendez-Bieler C, Urgelles AS, Navarro JS, Diaz-de-Heredia C

Survival and toxicity outcomes of hematopoietic stem cell transplantation for pediatric patients with Fanconi anemia: a unified multicentric national study from the Spanish Working Group for Bone Marrow Transplantation in Children

BONE MARROW TRANSPLANTATION

DOI: 10.1038/s41409-020-01172-y

Ayala R, Rapado I, Onecha E, Martinez-Cuadron D, Carreno-Tarragona G, Bergua JM, Vives S, Algarra JL, Tormo M, Martinez P, Serrano J, Herrera P, Ramos F, Salamero O, Lavilla E, Gil C, Lorenzo JLL, Vidriales MB, Labrador J, Falantes JF, Sayas MJ, Paiva B, Barragan E, Prosper F, Sanz MA, Martinez-Lopez J, Montesinos P

The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial

CANCERS

DOI: 10.3390/cancers13102458

IF: 6,639 Q1 D3

Sitges M, Boluda B, Garrido A, Morgades M, Granada I, Barragan E, Arnan M, Serrano J, Tormo M, Bergua JM, Colorado M, Salamero O, Esteve J, Benavente C, Perez-Encinas M, Coll R, Marti-Tutusaus JM, Brunet S, Sierra J, Sanz MA, Montesinos P, Ribera JM, Vive

Acute myeloid leukemia with inv(3)(q21

3q26

DOI: 10.1111/ejh.13417

IF: 2,22 Q: 3

Valhondo I, Hassouneh F, Lopez-Sejas N, Pera A, Sanchez-Correa B, Guerrero B, Bergua JM, Arcos MJ, Banas H, Casas-Aviles I, Sanchez-Garcia J, Serrano J, Martin C, Duran E, Alonso C, Solana R, Tarazona R

Characterization of the DNAM-1, TIGIT and TACTILE Axis on Circulating NK, NKT-Like and T Cell Subsets in Patients with Acute Myeloid Leukemia

CANCERS

DOI: 10.3390/cancers12082171

IF: 6,126 Q: 1

Rodriguez-Pinilla SM, Domingo-Domenech E, Climent F, Sanchez J, Seoane CP, Jimenez JL, Garcia-Cosio M, Caballero D, Munez OJB, Carpio C, Castellvi J, Pozo AM, Farre BG, Bendana A, Aliste C, Gonzalez AJ, de Villambrosia SG, Piris MA, Codina JG, Mayordomo-A

Clinical and pathological characteristics of peripheral T-cell lymphomas in a Spanish population: a retrospective study

BRITISH JOURNAL OF HAEMATOLOGY

DOI: 10.1111/bjh.16741

IF: 5,518 Q: 1

Gudiol C, Albasanz-Puig A, Laporte-Amargos J, Pallares N, Mussetti A, Ruiz-Camps I, Puerta-Alcalde P, Abdala E, Oltolini C, Akova M, Montejo M, Mikulska M, Martin-Davila P, Herrera F, Gasch O, Drgona L, Morales HP, Brunel AS, Garcia E, Isler B, Kern WV, M

Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

DOI: 10.1128/AAC.02494-19

IF: 4,904 Q: 1

Vega-García N, Benito R, Esperanza-Cebollada E, Llop M, Robledo C, Vicente-Garces C, Alonso J, Barragan E, Fernandez G, Hernandez-Sanchez JM, Martin-Izquierdo M, Maynou J, Minguela A, Montano A, Ortega M, Torrebadell M, Cervera J, Sanchez J, Jimenez-Velasco A, Riesco S, Hernandez-Rivas JM, Lassaletta A, Fernandez JM, Rives S, Dapena JL, Ramirez M, Camos M

Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia

JOURNAL OF PERSONALIZED MEDICINE

DOI: 10.3390/jpm10040244

IF: 4,433 Q: 1 D: 1

De Mier MVPR, Ojeda R, Alvarez-Lara MA, Navas A, Alonso C, Caballero-Villarraso J, Aljama P, Alvarez MA, Soriano S, Rodriguez M, Martin-Malo A

Hemodiafiltration with ultrafiltrate regeneration reduces free light chains without albumin loss in multiple myeloma patients

BMC NEPHROLOGY

DOI: 10.1186/s12882-020-01885-8

IF: 1,913 Q: 3

Serrano-Lopez J, Fernández JL, Lumbreras E, Serrano J, Martinez-Losada C, Martin C, Hernandez-Rivas JM, Sanchez-Garcia J

Machine learning applied to gene expression analysis of T-lymphocytes in patients with cGVHD

BONE MARROW TRANSPLANTATION

DOI: 10.1038/s41409-020-0848-y

IF: 4,725 Q: 1

Rodriguez-Medina C, Martínez-Cuadron D, Cano I, Gil C, Tormo M, Martinez-Sanchez MD, del Castillo TB, Serrano-Lopez J, Benavente C, Herrera-Puente P, Garcia-Boyero R, Lavilla-Rubira E, Amigo ML, Sayas-Llorisn MJ, Bergua-Burgues JM, Perez-Simon JA, Rodrigu

Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study

LEUKEMIA RESEARCH

DOI: 10.1016/j.leukres.2020.106352

IF: 2,214 Q: 3

Mira E, Yarce OA, Ortega C, Fernandez S, Pascual NM, Gomez C, Alvarez MA, Molina IJ, Lama R, Santamaria M

Rapid recovery of a SARS-CoV-2-infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE

DOI: 10.1016/j.jaip.2020.06.046

IF: 7,574 Q: 1

Ribera JM, Garcia O, Chapchap EC, Gil C, Gonzalez-Campos J, Barba P, Amigo ML, Moreno MJ, Lavilla E, Alonso N, Bergua JM, Tormo M, Ribera J, Sierra M, Martinez-Carballeira D, Mercadal S, Hernandez-Rivas JM, Vall-Llovera F, Genesca E, Cladera A, Novo A, Ab

Treatment of Frail Older Adults and Elderly Patients With Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia: Results of a Prospective Trial With Minimal Chemotherapy

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

DOI: 10.1016/j.clml.2020.03.011

IF: 2,298 Q: 3

Martinez-Cuadron D, Gil C, Serrano J, Rodriguez G, Perez-Oteyza J, Garcia-Boyero R, Jimenez-Bravo S, Vives S, Vidriales MB, Lavilla E, Perez-Simon JA, Tormo M, Colorado M, Bergua J, Lopez JA, Herrera P, Hernandez-Campo P, Gorrochategui J, Primo D, Rojas J; A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients

LEUKEMIA RESEARCH

2019 Jan;76:1-10

DOI: 10.1016/j.leukres.2018.11.006

IF: 2,066 Q3

Sobas M, Montesinos P, Boluda B, Bernal T, Vellenga E, Nomdedeu J, Gonzalez-Campos J, Chillon M, Holowiecka A, Esteve J, Bergua J, Gonzalez-Sanmiguel JD, Gil-Cortes C, Tormo M, Salamero O, Manso F, Fernandez I, de la Serna J, Moreno MJ, Perez-Encinas M, K; An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens

LEUKEMIA & LYMPHOMA

2019 Apr;60(4):1030-1035

DOI: 10.1080/10428194.2018.1516875

IF: 2,674 Q: 3

Megias-Vericat JE, Martinez-Cuadron D, Lopez JM, Bergua JM, Tormo M, Serrano J, Gonzalez A, de Oteyza JP, Vives S, Vidriales B, Herrera P, Vera JA, Martinez AL, de la Fuente A, Amador ML, Hernandez-Rivas JA, Fernandez MA, Cervero CJ, Morino D, Campo PH, G; Differences in ex-vivo Chemosensitivity to Anthracyclines in First Line Acute Myeloid Leukemia

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES

2019 Mar 1;11(1):e2019016

DOI: 10.4084/MJHID.2019.016

IF: 1,586 Q: 4

Garcia-Cadenas I, Yanez L, Jarque I, Martino R, Perez-Simon JA, Valcarcel D, Sanz J, Bermudez A, Munoz C, Calderon-Cabrera C, Garcia E, Alonso L, Suarez-Lledo M, Gonzalez Vicent M, Heras I, Viguria MC, Batlle M, Vazquez L, Lopez J, Solano C; Frequency, characteristics, and outcome of PTLD after allo-SCT: A multicenter study from the Spanish group of blood and marrow transplantation (GETH)

EUROPEAN JOURNAL OF HAEMATOLOGY

2019 Jun;102(6):465-471

DOI: 10.1111/ejh.13226

IF: 2,217 Q: 3

Alonso L, Gonzalez-Vicent M, Belendez C, Badell I, Sastre A, Rodriguez-Villa A, Bermudez-Cortes M, Hladun R, de Heredia CD; Hematopoietic stem cell transplantation in pediatric patients with thalassemia and sickle cell disease: An experience of the Spanish Working Group for Bone Marrow Transplantation in Children (GETMON)

MEDICINA CLINICA

2019 Feb 15;152(4):135-140

DOI: 10.1016/j.medcli.2018.05.013

IF: 1,277 Q: 3

Martos L, Fernandez-Pardo A, Lopez-Fernandez MF, Ibanez F, Herrero S, Tassies D, Gonzalez-Porras JR, Solmoirago MJ, Costa MJ, Reverter JC, Marco P, Roldan V, Lecumberri R, Velasco F, Oto J, Iruin G, Alonso MN, Vaya A, Bonanad S, Ferrando F, Marti E, Cid A; Identification of 58 Mutations (26 Novel) in 94 of 109 Symptomatic Spanish Probands with Protein C Deficiency

THROMBOSIS AND HAEMOSTASIS

2019 Sep;119(9):1409-1418

DOI: 10.1055/s-0039-1692440

IF: 4,733 Q: 1

Albasanz-Puig A, Gudiol C, Parody R, Tebe C, Akova M, Araos R, Bote A, Brunel AS, Calik S, Drgona L, Garcia E, Hemmati P, Herrera F, Ibrahim KY, Isler B, Kanj S, Kern W, de la Calle GM, Manzur A, Marin JI, Marquez-Gomez I, Martin-Davila P, Mikulska M, Mon; Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): study protocol of a retrospective multicentre international study

BMJ OPEN

2019 May 24;9(5):e025744

DOI: 10.1136/bmjopen-2018-025744

IF: 2,413 Q: 2

Ribera JM, Garcia O, Moreno MJ, Barba P, Garcia-Cadenas I, Mercadal S, Montesinos P, Barrios M, Gonzalez-Campos J, Martinez-Carballeira D, Gil C, Ribera J, Vives S, Novo A, Cervera M, Serrano J, Lavilla E, Abella E, Tormo M, Amigo ML, Artola MT, Genesca E; Incidence and outcome after first molecular versus overt recurrence in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia included in the ALL Ph08 trial from the Spanish PETHEMA Group

CANCER

2019 Aug 15;125(16):2810-2817

DOI: 10.1002/cncr.32156

IF: 6,102 Q: 1

Revilla N, Corral J, Minano A, Mingot-Castellano ME, Campos RM, Velasco F, Gonzalez N, Galvez E, Berrueco R, Fuentes I, Gonzalez-Lopez TJ, de la Morena-Barrio ME, Gonzalez-Porras JR, Vicente V, Lozano ML; Multirefractory primary immune thrombocytopenia; targeting the decreased sialic acid content

PLATELETS

2019;30(6):743-751

DOI: 10.1080/09537104.2018.1513476

IF: 3,106 Q: 2

Stahl M, DeVeaux M, Montesinos P, Itzykson R, Ritchie EK, Sekeres MA, Barnard J, Podoltsev NA, Brunner A, Komrokji RS, Bhatt VR, Al-Kali A, Cluzeau T, Santini V, Roboz GJ, Fenaux P, Litzow M, Fathi AT, Perreault S, Kim TK, Prebet T, Vey N, Verma V, Germin; Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia

LEUKEMIA & LYMPHOMA

2019 Jan;60(1):246-249

DOI: 10.1080/10428194.2018.1468893

IF: 2,674 Q: 3

Rodriguez-Veiga R, Montesinos P, Garcia E, Boluda B, Rojas R, Serrano J, Martinez-Cuadron D, Martin C, Sanz J, Tabares S, Pinana JL, Lorenzo I, Montoro J, Salavert M, Peman J, Jarque I, Solves P, Sanz GF, Torres A, Sanz MA; Validation of a multivariable prediction model for post-engraftment invasive fungal disease in 465 adult allogeneic hematopoietic stem cell transplant recipients

MYCOSES

2019 May;62(5):418-427

DOI: 10.1111/myc.12891

IF: 3,065 Q: 2

Bento L, Bastida JM, Garcia-Cadenas I, Garcia-Torres E, Rivera D, Bosch-Vilaseca A, De Miguel C, Martinez-Munoz ME, Fernandez-Aviles F, Roldan E, Chinea A, Yanez L, Zudaire T, Vaz CP, Espigado I, Lopez J, Valcarcel D, Duarte R, Cabrera R, Herrera C, Gonza

Thrombopoietin Receptor Agonists for Severe Thrombocytopenia after Allogeneic Stem Cell Transplantation: Experience of the Spanish Group of Hematopoietic Stem Cell Transplant; Real life outcomes of patients aged >= 75 years old with acute promyelocytic leukemia: experience of the PETHEMA registry

LEUKEMIA & LYMPHOMA

DOI: 10.1080/10428194.2019.1607327

IF: 2,674 Q: 3

Martinez-Losada C, Serrano-Lopez J, Serrano-Lopez J, Noguera NI, Garza E, Piredda L, Lavorgna S, Consalvo MAI, Ottone T, Alfonso V, Peinado JR, Garcia-Ortiz MV, Morales-Ruiz T, Jerez A, Hurtado AM, Montesinos P, Cervera J, Such E, Ibanez M, Sempere A, Sanz MA, Lo-Coco F, Sanchez-Garcia J

Clonal genetic evolution at relapse of favorable-risk acute myeloid leukemia with NPM1 mutation is associated with phenotypic changes and worse outcomes

HAEMATOLOGICA

IF: 9,09 Q: 1 D: 1

Sanchez-Garcia J, Falantes J, Perez AM, Hernandez-Mohedo F, Hermosin L, Torres-Sabariego A, Bailen A, Hernandez-Sanchez JM, Rodriguez MS, Casano FJ, Calderon C, Labrador M, Vahi M, Serrano J, Lumbreras E, Hernandez-Rivas JM

Prospective randomized trial of 5 days azacitidine versus supportive care in patients with lower-risk myelodysplastic syndromes without 5q deletion and transfusion-dependent anemia

LEUKEMIA & LYMPHOMA

IF: 2,644 Q: 2

Perez-Sanchez C, Arias-de la Rosa I, Aguirre MA, Luque-Tevar M, Ruiz-Limon P, Barbarroja N, Jimenez-Gomez Y, Abalos-Aguilera MC, Collantes-Estevez E, Segui P, Velasco F, Herranz MT, Lozano-Herrero J, Hernandez-Vidal MJ, Martinez C, Gonzalez-Conejero R, Radin M, Sciascia S, Cecchi I, Cuadrado MJ, Lopez-Pedrera C

Circulating microRNAs as biomarkers of disease and typification of the atherothrombotic status in antiphospholipid syndrome

HAEMATOLOGICA

IF: 9,09 Q: 1 D: 1

Stahl M, DeVeaux M, Montesinos P, Itzykson R, Ritchie EK, Sekeres MA, Majhail N, Barnard J, Podoltsev NA, Brunner AM, Komrokji RS, Bhatt VR, Al-Kali A, Cluzeau T, Santini V, Roboz GJ, Fenaux P, Litzow M, Fathi AT, Perreault S, Kim TK, Prebet T, Vey N, Verma V, Kobbe G, Bergua J, Serrano J, Gore SD, Zeidan AM

Allogeneic Hematopoietic Stem Cell Transplantation Following the Use of Hypomethylating Agents among Patients with Relapsed or Refractory AML: Findings from an International Retrospective Study

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

IF: 4,484 Q: 1

de la Fuente FDA, Duran MS, Alvarez MA, Sanroman IL, Dios AM, Tamayo RR, Garcia R, Gonzalez MS, Prieto E, Barez A, Escalante F, Tejedor A, Ballesteros M, Cabanas V, Capote FJ, Couto C, Garzon S, Gonzalez-Pardo M, Manteca MVM

Subcutaneous bortezomib in newly diagnosed patients with multiple myeloma nontransplant eligible: Retrospective evaluation

SEMINARS IN HEMATOLOGY

IF: 3,926 Q: 2

Stahl M, DeVeaux M, Montesinos P, Itzykson R, Ritchie EK, Sekeres MA, Barnard JD, Podoltsev NA, Brunner AM, Komrokji RS, Bhatt VR, Al-Kali A, Cluzeau T, Santini V, Fathi AT, Roboz GJ, Fenaux P, Litzow MR, Perreault S, Kim TK, Prebet T, Vey N, Verma V, Germing U, Bergua JM, Serrano J, Gore SD, Zeidan AM

Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort

BLOOD ADVANCES

Martinez-Cuadron D, Boluda B, Martinez P, Bergua J, Rodriguez-Veiga R, Esteve J, Vives S, Serrano J, Vidriales B, Salamero O, Cordon L, Sempere A, Jimenez-Ubieto A, Prieto-Delgado J, Diaz-Beya M, Garrido A, Benavente C, Perez-Simon JA, Moscardo F, Sanz MA, Montesinos P

A phase I-II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia

ANNALS OF HEMATOLOGY

IF: 2,845 Q: 2

Serrano-Lopez J, Nattamai K, Pease NA, Shephard MS, Wellendorf AM, Sertorio M, Smith EA, Geiger H, Wells SI, Cancelas JA, Privette Vinnedge LM

2

-Loss of DEK induces radioresistance of murine restricted hematopoietic progenitors

IF: 2

436 Q: 2

Zhang C, D'Alessandro A, Wellendorf AM, Mohmoud F, Serrano-Lopez J, Perentesis JP, Komurov K, Alexe G, Stegmaier K, Whitsett JA, Grimes HL, Cancelas JA

3

- KLF5 controls glutathione metabolism to suppress p190-BCR-ABL+ B-cell lymphoblastic leukemia

IF: 3,45 Q: 2

Stahl M, DeVeaux M, Montesinos P, Itzykson R, Ritchie EK, Sekeres MA, Barnard J, Podoltsev NA, Brunner A, Komrokji RS, Bhatt VR, Al-Kali A, Cluzeau T, Santini V, Roboz GJ, Fenaux P, Litzow M, Fathi AT, Perreault S, Kim TK, Prebet T, Vey N, Verma V, Germing U, Bergua J, Serrano J, Gore SD, Zeidan AM

Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia

LEUK LYMPHOMA

IF: 2

644 Q: 2